Gender-Related Differences in Clinical Characteristics and Outcomes of Premature Coronary Artery Disease: Insight from the FOCUS Registry

Table 3

Clinical outcomes comparing male and female for 12 months.

Outcomes	Total	Male	Female	p value
(Follow-up for 1385 patients)	(n=1385)	(n=868)	(n=517)
All cause death	13 (0.9%)	7 (0.8%)	6 (1.2%)	0.709
Cardiovascular death	8 (0.6%)	4 (0.5%)	4 (0.8%)	0.706
MI	31 (2.2%)	19 (2.2%)	12 (2.3%)	0.872
Nonfatal MI	29 (2.1%)	18 (2.1%)	11 (2.1%)	0.946
Any revascularization	27 (1.9%)	15 (1.7%)	12 (2.3%)	0.440
TVR	10 (0.7%)	4 (0.5%)	6 (1.2%)	0.246
Non-TVR	17 (1.2%)	11 (1.3%)	6 (1.2%)	0.861
MACE	47 (3.4%)	26 (3.0%)	21 (4.1%)	0.289
Definite/probable ST	7 (0.5%)	3 (0.3%)	4 (0.8%)	0.487
DAPT	1054 (76.1%)	651 (75.0%)	403 (77.9%)	0.213

Values are presented as n (percentage).
DAPT: dual antiplatelet therapy; MACE: major adverse cardiovascular event; MI: myocardial infarction; ST: stent thrombosis; and TVR: target vascular revascularization.